KRTX News and Press, Karuna Therapeutics Inc. From 01/23/20

Genprex (NASDAQ: GNPX )  -37%  on pricing $8M stock offering. More news on: Genprex, Inc., Applied Genetic Technologies Corporation, Tetraphase Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Gainers: SLM   +16.1% . EYE   +11.0%.  PTC   +7.8% . RIGL   +5.9% . CTXS   +4.1% . More news on: SLM Corporation, National Vision Holdings, Inc., PTC Inc., Stocks on the move, , Read more ...

Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...

The following slide deck was published by Karuna Therapeutics, Inc. in conjunction with this Read more ...

Aptose Biosciences (APS CN) initiated with Overweight rating at Piper Sandler. Shares up  2%  premarket in U.S. (NASDAQ: APTO ). More news on: Aptose Biosciences Inc., BioDelivery Sciences International, Inc., BiomX Inc., Healthcare stocks news, Stocks on the move, , Read mor...

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chi...

Biotech Pulse The biotech group closed 2019 with its longest rally of the year. It was a welcome change from what had mostly been an uphill battle. While the broader market was sailing from one high to another, biotechs and pharmaceuticals (biopharma) were still marking their 2019 lows in ea...

Investing in IPO stocks  can be fun, but also risky. There can be a scarcity of information about a brand new equity. And sometimes the underwriters intentionally lowball the value of a company, in order to hype the stock (and reward the bank's clients who bought shares on the cheap). None...

Investing in biotech stocks can be very risky. Positive results from a clinical trial can send a stock's valuation through the roof, while a poor result can send it crashing in a hurry. A great example is what's happened with Karuna Therapeutics (NASDAQ: KRTX)  and the wild ride it has t...

The FDA's approval of Intra-Cellular Therapies' ( ITCI +191.6% ) schizophrenia drug bodes well for other companies with therapies for the central nervous system, writes Stifel analyst Paul Matteis. More news on: Intra-Cellular Therapies, Inc., Sage Therapeutics, Inc., ACADIA Pharmaceutic...